Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share it with others. That’s right. Send us your changes and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the ongoing layoffs. Despite the downsizing, there is movement. Here are some of the latest comings and goings. Recognize anyone?
And here is our regular feature in which we highlight a different person each week. This time around, we note that Bristol-Myers Squibb promoted Paul Biondi to senior vice president, head of business development. Biondi, who joined the drug maker in 2002, most recently was senior vice president, head of R&D operations.
Merck KGaA promoted Stefan Oschmann to chief executive officer;
Remedy Pharmaceuticals hired Richard Steinhart as chief financial officer;
PharmApprove hired Renu Gupta as a clinical regulator advisor;
Biothera Pharmaceuticals hired Jose Iglesias as chief medical officer;
Adare Pharmaceuticals hired Jim Jogerst as vice president, corporate development;
Ovid Therapeutics named Anna Kazanchyan as senior vp, business development;
Nabriva Therapeutics hired Will Sargent as vp, commercial strategy and investor relations;
Biomunex Pharmaceuticals hired Eugene Zhukovsky as chief scientific officer;
Pacgen promoted Christina Yip to president;
Pacgen hired Julie Rezler as vice president, corporate development;
Medgenics hired Liza Squired as vp, R&D, therapeutic head, neuroscience;
Viamet Therapeutics hired Oren Cohen as chief medical officer;
Atosa Genetics hired Janet Rose Rea as vp, regulatory affairs and quality;
Regen BioPharma hired Harry Lander as president;Print This Post